News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
169,371 Results
Type
Article (6782)
Company Profile (24)
Press Release (162558)
Multimedia
Podcasts (21)
Webinars (3)
Section
Business (45731)
Career Advice (482)
Deals (9185)
Drug Delivery (19)
Drug Development (32998)
Employer Resources (18)
FDA (4337)
Job Trends (3621)
News (88655)
Policy (6305)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (1)
Academia (484)
Academic (1)
Accelerated approval (11)
Adcomms (5)
Allergies (58)
Alliances (7306)
ALS (69)
Alzheimer's disease (694)
Antibody-drug conjugate (ADC) (122)
Approvals (4598)
Artificial intelligence (126)
Autoimmune disease (59)
Automation (11)
Bankruptcy (63)
Best Places to Work (3401)
BIOSECURE Act (3)
Biosimilars (62)
Biotechnology (18)
Bladder cancer (84)
Brain cancer (23)
Breast cancer (331)
Cancer (2355)
Cardiovascular disease (183)
Career advice (387)
Career pathing (8)
CAR-T (86)
CDC (8)
Celiac Disease (1)
Cell therapy (237)
Cervical cancer (12)
Clinical research (30497)
Collaboration (434)
Compensation (130)
Complete response letters (15)
COVID-19 (735)
CRISPR (28)
C-suite (143)
Cystic fibrosis (68)
Data (3558)
Denatured (1)
Depression (61)
Diabetes (265)
Diagnostics (1684)
Digital health (7)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (73)
Drug pricing (25)
Drug shortages (2)
Duchenne muscular dystrophy (78)
Earnings (33717)
Editorial (14)
Employer branding (1)
Employer resources (18)
Events (28858)
Executive appointments (170)
FDA (5883)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (3)
Frontotemporal dementia (6)
Funding (460)
Gene editing (66)
Generative AI (7)
Gene therapy (209)
GLP-1 (449)
Government (875)
Grass and pollen (4)
Guidances (303)
Healthcare (4539)
HIV (25)
Huntington's disease (18)
IgA nephropathy (70)
Immunology and inflammation (87)
Immuno-oncology (29)
Indications (58)
Infectious disease (840)
Inflammatory bowel disease (81)
Inflation Reduction Act (2)
Influenza (62)
Intellectual property (84)
Interviews (90)
IPO (5742)
IRA (7)
Job creations (450)
Job search strategy (322)
JPM (22)
Kidney cancer (12)
Labor market (19)
Layoffs (84)
Leadership (10)
Legal (821)
Liver cancer (39)
Longevity (4)
Lung cancer (359)
Lymphoma (222)
Machine learning (11)
Management (5)
Manufacturing (145)
MASH (86)
Medical device (2899)
Medtech (2910)
Mergers & acquisitions (3869)
Metabolic disorders (594)
Multiple sclerosis (65)
NASH (6)
Neurodegenerative disease (124)
Neuropsychiatric disorders (38)
Neuroscience (1212)
NextGen: Class of 2026 (1150)
Non-profit (633)
Now hiring (2)
Obesity (244)
Opinion (55)
Ovarian cancer (72)
Pain (90)
Pancreatic cancer (109)
Parkinson's disease (138)
Partnered (9)
Patents (128)
Patient recruitment (207)
Peanut (21)
People (6958)
Pharmaceutical (9)
Pharmacy benefit managers (5)
Phase 1 (8772)
Phase 2 (15000)
Phase 3 (9866)
Pipeline (2909)
Policy (42)
Postmarket research (873)
Preclinical (2752)
Press Release (7)
Prostate cancer (112)
Psychedelics (17)
Radiopharmaceuticals (97)
Rare diseases (351)
Real estate (479)
Recruiting (9)
Regulatory (6334)
Reports (22)
Research institute (469)
Resumes & cover letters (96)
Rett syndrome (15)
RNA editing (4)
RSV (33)
Schizophrenia (77)
Series A (113)
Series B (56)
Sickle cell disease (43)
Special edition (10)
Spinal muscular atrophy (46)
Sponsored (13)
Startups (625)
State (1)
Stomach cancer (5)
Supply chain (19)
Tariffs (18)
The Weekly (20)
Vaccines (300)
Venture capital (24)
Weight loss (136)
Women's health (22)
Worklife (6)
Date
Last 7 days (218)
Last 30 days (762)
Last 365 days (12347)
2026 (1026)
2025 (12493)
2024 (12856)
2023 (13988)
2022 (16474)
2021 (16642)
2020 (14864)
2019 (10618)
2018 (7894)
2017 (8158)
2016 (6896)
2015 (8421)
2014 (5647)
2013 (3770)
2012 (3991)
2011 (4430)
2010 (3914)
Location
Africa (155)
Alabama (16)
Alaska (1)
Arizona (48)
Arkansas (3)
Asia (10445)
Australia (1795)
California (4426)
Canada (1255)
China (452)
Colorado (171)
Connecticut (244)
Delaware (159)
Europe (26016)
Florida (607)
Georgia (150)
Hawaii (2)
Idaho (12)
Illinois (287)
India (17)
Indiana (194)
Iowa (5)
Japan (196)
Kansas (46)
Kentucky (16)
Louisiana (8)
Maine (27)
Maryland (458)
Massachusetts (3163)
Michigan (83)
Minnesota (187)
Mississippi (3)
Missouri (38)
Montana (5)
Nebraska (2)
Nevada (47)
New Hampshire (12)
New Jersey (1403)
New Mexico (2)
New York (1249)
North Carolina (378)
North Dakota (2)
Northern California (2229)
Ohio (84)
Oregon (9)
Pennsylvania (921)
Puerto Rico (3)
Rhode Island (6)
South America (281)
South Carolina (2)
Southern California (1765)
Tennessee (42)
Texas (691)
United States (15246)
Utah (93)
Vermont (1)
Virginia (86)
Washington D.C. (24)
Washington State (325)
Wisconsin (25)
169,371 Results for "a2 biotherapeutics.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Unravel Biosciences and The SCN2A Foundation Announce Drug Discovery Collaboration
January 29, 2026
·
2 min read
Press Releases
A2 Biotherapeutics Announces FDA Clearance of IND for A2B543 for Treatment of Adults with Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors that Express Mesothelin and Have Lost HLA-A*02 Expression
January 9, 2026
·
5 min read
Press Releases
MIRA Pharmaceuticals Initiates Final Cohort of Ketamir-2 Phase 1 Clinical Study as Company Prepares for Phase 2a Study
February 3, 2026
·
6 min read
Press Releases
Dewpoint Therapeutics Doses First Patient in Phase 1a/2a Trial DPTX3186 for the Treatment of Advanced Solid Tumors, Focused on Gastric Cancer
February 5, 2026
·
3 min read
Press Releases
NMD Pharma announces topline results from its Phase 2a study of ignaseclant in Charcot-Marie-Tooth disease Types 1 and 2
February 3, 2026
·
10 min read
Press Releases
Novo Nordisk A/S: CagriSema demonstrated superior HbA1c reduction of 1.91%-points and weight loss of 14.2% in adults with type 2 diabetes in the REIMAGINE 2 trial
February 3, 2026
·
6 min read
Press Releases
Can-Fite Completes Patient Enrollment in Phase 2a Pancreatic Cancer Study of Namodenoson
January 20, 2026
·
5 min read
Press Releases
Skye Reports Positive CBeyond Phase 2a Extension Interim Study Results for Nimacimab in Combination With Semaglutide
February 2, 2026
·
9 min read
Press Releases
AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions
January 22, 2026
·
4 min read
Press Releases
TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138
February 5, 2026
·
4 min read
1 of 16,938
Next
